At the beginning of 2019, Karger became a major shareholder in the award-winning company that has developed the first biomedical-specific AI Big Data Visual Analytics Engine. On January 4, 2019, Karger Publishers acquired a substantial minority of the shares of Quertle, Inc. … Read More »

Recipharm, the contract development and manufacturing organisation (CDMO), today announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the Februa … Read More »

The world’s largest maker of generic drugs is looking for growth in an unlikely place: high-price biotech medicines. Teva Pharmaceutical Industries Ltd., which supplies more than one in 10 drugs taken in the U.S., has struggled in recent years with slumping generics prices a … Read More »

Another major acquisition was just announced in a big week for the robotics sector. Johnson & Johnson, purveyors of baby powder, pharma, and medical devices, will acquire surgical robotics company Auris Health for $3.4 billion, with another $2+ billion in milestone payme … Read More »

San Diego, CA (USA) and Basel (CH) 13 February 2019 – Emerald Health Pharmaceuticals and Lonza have announced an agreement for the large-scale manufacturing of a new synthetic derivative of cannabidiol (CBD) and its oral drug product for the treatment of multiple sclerosis ( … Read More »

Corpus Christi, Texas, Feb. 13, 2019 (Business Wire) – Corpus Christi Women’s Clinic, a large, full-service women’s health practice in Corpus Christi, Texas, has partnered with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physici … Read More »

A Series of Interviews With Transformational Business Leaders: Miles D. White, Chairman and CEO Abbott Laboratories. During his 20-year tenure, White has anticipated the future of healthcare and reshaped the company to keep it relevant to changes in science, medicine, busine … Read More »

Sanofi has become the latest big pharma firm to appoint a chief digital officer, choosing Ameet Nathwani to take up the position, adding onto his current role of executive vice president, chief medical officer. In the newly-created role, Dr Nathwani will be responsible for e … Read More »

The FDA has started a speedy review of Merck KGaA and Pfizer’s new combination regimen for advanced kidney cancer, setting up a possible approval in June and piling more pressure on Bristol-Myers Squibb. The two companies have filed their partnered PD-L1 inhibitor Bavencio ( … Read More »

Laval, Quebec, Feb. 12, 2019 – Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development, including preclinical, clinical, bioanalysis, and research services, has unveiled a new brand identity and web … Read More »

Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new director of business management for the USA and Canada to accelerate growth in the region. With over 8 years of experience working in the North American CDMO industry, Kieran Chouh … Read More »

Boston, MA and Orlando, FL – February 12, 2019- Health care information technology is undergoing unprecedented change—and the Healthcare Information and Management Systems Society (HIMSS) Annual Conference is the premier event to learn about the latest technologies, trends, … Read More »

BURLINGTON, Ontario and MARKHAM, Ontario, /PRNewswire/ — Boehringer Ingelheim (Canada) Ltd. and IBM Canada (NYSE: IBM) announced today at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of bloc … Read More »

 Plymouth Meeting, PA – February 12, 2019: Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experience. Pharmaceutical companies around the world will convene at the 10th annual Summit of … Read More »

BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019 /PRNewswire/ — Praluent® (alirocumab) will be made available at a new reduced U.S. list price of $5,850 annually, a 60% reduction from the original price, for both the 75 mg and 150 mg doses, beginning in early March. The … Read More »

The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, is today launching the next phase of its blockchain project. This phase will focus on the development of practical life science R&D use cases that … Read More »

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its wor … Read More »

TOKYO, Feb 8, 2019 – (JCN Newswire) – Hitachi, Ltd., Jichi Medical University (JMU), International University of Health and Welfare (IUHW) and Chuo University (Chuo-U) have developed fundamental technology to support the early differential diagnosis of concurrent autism spec … Read More »

Exhibitor Innovations Best Innovation in Drug Delivery Device: Connected Health Platform by Phillips-Medisize Cartridge-based wearable device by Stevanato Group Best Innovation in Solid Dosage Packaging: Push Tab® by Huhtamaki Flexible Packaging Germany GmbH & Co.KG IQ-D … Read More »

Certara has recently published four peer-reviewed MIPD papers; its progress is generating strong interest from industry, health care professionals and regulators Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and marke … Read More »